Sarah Kaplan Browne
CIK: 0002158844
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MTVA
MetaVia Inc.
Officer
Discretionary Trading P&L
Holdings
About Browne Sarah Kaplan
Browne Sarah Kaplan (SEC CIK 0002158844) files insider reports with the SEC as Chief Medical Officer of MetaVia Inc. (MTVA).
Signal8 holds 2 ownership filings by Browne Sarah Kaplan (1 Form 3, 1 Form 4), filed on Oct 13, 2026. Those filings report 1 transaction, the latest on Oct 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Browne Sarah Kaplan's filings is in CAMBRIDGE, MA.
Recent filings by Browne Sarah Kaplan
- Oct 12, 2026: Grant or award of MTVA shares (Form 4, code A).
Other insiders filing for MetaVia Inc. (MTVA)
- Tursi James Patrick, Director
- STRICKLAND D GORDON, Director
- Salsbury Michael, Director
- GROVES JASON L, Director
- KOVEN ANDREW I, Director
- Glickman Mark A, Director